2013 Analysis of the HIV/AIDS Diagnostics Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts

April 2013 | 292 pages | ID: 2816A8688CEEN
Venture Planning Group

Abstracts

2013 Analysis of the HIV/AIDS Diagnostics Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape

The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for HIV-1/2, HIV Ag, HTLV-I/II, Western Blot and other confirmatory tests performed in the following markets:

• Hospitals
• Public Health Labs
• Commercial/Private Labs
• Blood Banks
• Physician Offices
• Ambulatory Care Centers

For each country, in addition to the test volume and sales projections, the report presents the sales and market share estimates for major suppliers of AIDS tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies profiles leading suppliers and recent market entrants developing innovative technologies and products and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 292 pages and 36 tables

Contents

I. INTRODUCTION

II. AEROMONADS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
  1. Molecular Diagnostics
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Other

III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

IX. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT